Clinical Trial Update: Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) [Phase 2]

View source ↗

Summary

Phase II clinical trial of KPS-0373 for Spinocerebellar Degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinocerebellar Degeneration

Drugs mentioned

• KPS-0373

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Spinocerebellar Degeneration | Phase 2 | Status: COMPLETED